Abstract

Selenium is an essential micronutrient that suppresses the redox-sensitive transcription factor NF-kappaB-dependent pro-inflammatory gene expression. To understand the molecular mechanisms underlying the anti-inflammatory property of selenium, we examined the activity of a key kinase of the NF-kappaB cascade, IkappaB-kinase beta (IKKbeta) subunit, as a function of cellular selenium status in murine primary bone marrow-derived macrophages and RAW264.7 macrophage-like cell line. In vitro kinase assays revealed that selenium supplementation decreased the activity of IKKbeta in lipopolysaccharide (LPS)-treated macrophages. Stimulation by LPS of selenium-supplemented macrophages resulted in a time-dependent increase in 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) formation, an endogenous inhibitor of IKKbeta activity. Further analysis revealed that inhibition of IKKbeta activity in selenium-supplemented cells correlated with the Michael addition product of 15d-PGJ2 with Cys-179 of IKKbeta, while the formation of such an adduct was significantly decreased in the selenium-deficient macrophages. In addition, anti-inflammatory activities of selenium were also mediated by the 15d-PGJ2-dependent activation of the peroxisome proliferator-activated nuclear receptor-gamma in macrophages. Experiments using specific cyclooxygenase (COX) inhibitors and genetic knockdown approaches indicated that COX-1, and not the COX-2 pathway, was responsible for the increased synthesis of 15d-PGJ2 in selenium-supplemented macrophages. Taken together, our results suggest that selenium supplementation increases the production of 15d-PGJ2 as an adaptive response to protect cells against oxidative stress-induced pro-inflammatory gene expression. More specifically, modification of protein thiols by 15d-PGJ2 represents a previously undescribed code for redox regulation of gene expression by selenium.

Highlights

  • Macrophages play central roles as effector cells in inflammatory reactions and cell-mediated immune responses

  • The selenium-supplemented and selenium-deficient bone marrow-derived macrophages (BMDMs) and RAW264.7 macrophages were used in all the experiments described below

  • Supplementation with selenium has been positively correlated with lowered incidences in prostate cancer and HIV replication, where macrophage activation is a crucial step in the inflammatory processes that form the underlying basis of disease progression [38]

Read more

Summary

Introduction

Macrophages play central roles as effector cells in inflammatory reactions and cell-mediated immune responses While performing these functions, these cells produce such reactive oxygen species in the form of superoxide anion, hydrogen peroxide, hydroxyl, and lipid peroxyl radicals along with a great number of pro-inflammatory substances, including complement components, PGs, chemokines, and cytokines like interleukin-1␤ and tumor necrosis factor-␣ [1]. These cells produce such reactive oxygen species in the form of superoxide anion, hydrogen peroxide, hydroxyl, and lipid peroxyl radicals along with a great number of pro-inflammatory substances, including complement components, PGs, chemokines, and cytokines like interleukin-1␤ and tumor necrosis factor-␣ [1] Such reactions represent a potentially toxic insult, which if not counteracted, will lead to membrane dysfunction, DNA damage and inactivation of proteins, leading to the onset and/or progression of many disease pathologies [2,3,4]. The present study is based on the hypothesis that the anti-inflammatory role of selenium occurs, in part, via 15d-PGJ2-dependent intracellular signaling pathways in macrophages and that COX-1 plays a pivotal role in the control of NF-␬B activity

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call